Abstract
Objective: Investigate the use of intranasal corticosteroids (ICS) by otolaryngologists with a predominantly pediatric practice, a national inquiry has been conducted in a European country.
Method: Participants: 212 otolaryngologists, representing around 10% of the specialty, answered the survey (M/F ratio=179/33). The mean age of this population was 52 ± 8.4 years, with a mean time in practice of 20.7 ± 9 years.
Results: Disease treated by ICS were chronic rhinosinusitis in 39.2% for a mean duration of 30 days in 62.2% of the cases, aergic rhinitis in 69.2 %, nasal polyposis in 67.2%, and OME in 30.2%. Acute rhinosinusitis was considered for treatment by intranasal corticosteroids by only 8.5% of otolaryngologists. Adenoid hypertrophy was treated in 16% of cases by ICS. Symptoms considered for treatment by ICS were nasal obstruction (88.6%), rhinorrhea (67.6%), nasal itching (66.1%), ocular symptoms (41.2%), sneezing (63%), olfactory troubles (73.2%), dyspnea (76%), edema of nasal mucosa (76.2%). Fever was never an indication (75%).
Conclusion: According to this nationwide survey nasal polyposis and allergic rhinitis are the most frequent indications for ICS treatment in children.
Get full access to this article
View all access options for this article.